SAN FRANCISCO — AbbVie, a global, research-based biopharmaceutical company, and MBC BioLabs announced Tuesday that Bacchus Therapeutics and PTM Therapeutics have each won a 2020 AbbVie Golden Ticket at MBC BioLabs. The companies will each receive one year of lab bench space and access to core facilities at the MBC BioLabs life sciences incubator, and have opportunities to interact with
NORTH CHICAGO, Ill. — AbbVie and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion, based on the closing price of AbbVie’s common stock of $78.45 on June 24, 2019. (PRNewsfoto/AbbVie) “This is a
NORTH CHICAGO, Ill. — AbbVie announced a donation of $100 million to two organizations, Direct Relief and Habitat for Humanity International, to strengthen access to healthcare and housing in Puerto Rico. The organizations will receive $50 million each. This donation is an extension of the more than $4 million AbbVie provided following the unprecedented natural disasters of 2017. “AbbVie has a longstanding commitment
DEERFIELD, Ill. — Gulden Mesara-Dogan has joined Walgreens Boots Alliance (WBA) as vice president of communications USA, the division that includes the Walgreens and Duane Reade drug chains. In the role, Mesara-Dogan will oversee communications serving WBA’s enterprise and USA businesses and operations, including the Walgreens communications division, Walgreens external communications, and the WBA internal communications and
RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals Inc. has gained Food and Drug Administration approval for Cyltezo, a biosimilar of Humira from AbbVie Inc. Boehringer Ingelheim said Tuesday that Cyltezo (adalimumab-adbm) comes in a prefilled syringe and is indicated to treat a range of chronic inflammatory diseases, including moderate to severe active rheumatoid arthritis, moderate to
CHESTNUT RIDGE, N.Y. — Par Pharmaceutical has released testosterone gel 1%, a generic version of AndroGel 1% from AbbVie. Par said Wednesday that its testosterone gel 1% product is available in 2.5g and 5g aluminum foil packets containing 25 mg or 50 mg of testosterone, respectively. The company noted that it previously entered into a
WOONSOCKET, R.I. — CVS Health and Gilead Sciences have reached a deal to make Gilead’s hepatitis C drugs, Harvoni and Sovaldi, the exclusive option for patients on its commercial drug list, as well as for those it manages on health care exchanges, Medicare Part D and Medicaid. The move partly counteracts a recent decision by